Recommendations for laboratory testing of UK patients with acute myeloid leukaemia (vol 200, pg 150, 2023)

被引：0
|
作者：
Mehta, Priyanka [1 ]
机构：
[1] Univ Hosp Bristol & Weston NHS Fdn Trust, Haematol, Bristol, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 03期
关键词：
D O I：
10.1111/bjh.18713
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：589 / 589
页数：1
相关论文
共 50 条
  • [21] Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 31, pg 697, 2020)
    Heuser, M.
    Ofran, Y.
    Boissel, N.
    Mauri, S. Brunet
    Craddock, C.
    Janssen, J.
    Wierzbowska, A.
    Buske, C.
    ANNALS OF ONCOLOGY, 2021, 32 (06) : 821 - 821
  • [22] Acute vestibular migraine: a ghost diagnosis in patients with acute vertigo (vol 270, pg 6155, 2023)
    Rocha, Maria Francisca
    Sacks, Benjamin
    Al Lamki, Amira
    Koohi, Nehzat
    Kaski, Diego
    JOURNAL OF NEUROLOGY, 2024, 271 (01) : 627 - 627
  • [23] Economic analysis of filgrastim use for patients with acute myeloid leukaemia in the UK - A comparison of collection methods of resource use data
    Standaert, B
    Goldstone, J
    Lu, ZJ
    Erder, MH
    Yin, JL
    PHARMACOECONOMICS, 2002, 20 (10) : 665 - 674
  • [24] Current Recommendations for Laboratory Testing and Use of Bone Turnover Markers in Management of Osteoporosis (vol 32, pg 105, 2012)
    Glendenning, F.
    Laffer, L. L.
    Weber, H. K.
    Musk, A. A.
    Vasikaran, S. D.
    ANNALS OF LABORATORY MEDICINE, 2012, 32 (03) : 242 - 242
  • [25] The international consensus classification of myeloid neoplasms and acute leukemias: Myeloproliferative neoplasms(vol 98,pg 166,2023)
    Thiele, Juergen
    Kvasnicka, Hans Michael
    Orazi, Attilio
    Gianelli, Umberto
    Gangat, Naseema
    Vannucchi, Alessandrom M.
    Barbui, Tiziano
    Arber, Daniel A.
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (03) : 544 - 545
  • [26] Reducing stroke risk in hypertensive patients: Asian Consensus Conference recommendations. (vol 1, pg 150, 2006)
    Liu, L. S.
    Caguioa, E. S.
    Park, C. G.
    Quek, D. K. L.
    Saito, I
    Venketasubramanian
    Wong, K. S. L.
    Reid, J. L.
    INTERNATIONAL JOURNAL OF STROKE, 2007, 2 (01) : 72 - 72
  • [27] Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia (vol 25, pg 395, 2001)
    Ferrao, P
    Sincock, P
    Cole, S
    Ashman, L
    LEUKEMIA RESEARCH, 2001, 25 (09) : 827 - 827
  • [28] Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia (vol 52, pg 17, 2003)
    Westers, TM
    Stam, AGM
    Scheper, RJ
    Regelink, JC
    Nieuwint, AWM
    Schuurhuis, GJ
    van de Loosdrecht, AA
    Ossenkoppele, GJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (08) : 523 - 524
  • [29] An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia (vol 4, pg 24, 2023)
    Lasry, Audrey
    Nadorp, Bettina
    Fornerod, Maarten
    Nicolet, Deedra
    Wu, Huiyun
    Walker, Christopher J.
    Sun, Zhengxi
    Witkowski, Matthew T.
    Tikhonova, Anastasia N.
    Guillamot-Ruano, Maria
    Cayanan, Geraldine
    Yeaton, Anna
    Robbins, Gabriel
    Obeng, Esther A.
    Tsirigos, Aristotelis
    Stone, Richard M.
    Byrd, John C.
    Pounds, Stanley
    Carroll, William L.
    Gruber, Tanja A.
    Eisfeld, Ann-Kathrin
    Aifantis, Iannis
    NATURE CANCER, 2023, 4 (1) : 149 - 149
  • [30] Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients (vol 37, pg 2187, 2023)
    Jahn, Ekaterina
    Saadati, Maral
    Fenaux, Pierre
    Gobbi, Marco
    Roboz, Gail J.
    Bullinger, Lars
    Lutsik, Pavlo
    Riedel, Anna
    Plass, Christoph
    Jahn, Nikolaus
    Walter, Claudia
    Holzmann, Karlheinz
    Hao, Yong
    Naim, Sue
    Schreck, Nicholas
    Krzykalla, Julia
    Benner, Axel
    Keer, Harold N.
    Azab, Mohammad
    Dohner, Konstanze
    Dohner, Hartmut
    LEUKEMIA, 2023, 37 (11) : 2336 - 2337
12345